The latest closing stock price for Reviva Pharmaceuticals Holdings as of November 22, 2024 is 1.14.
An investor who bought $1,000 worth of Reviva Pharmaceuticals Holdings stock at the IPO in 2018 would have $-883 today, roughly -1 times their original investment - a -30.02% compound annual growth rate over 6 years.
The all-time high Reviva Pharmaceuticals Holdings stock closing price was 11.88 on September 28, 2020.
The Reviva Pharmaceuticals Holdings 52-week high stock price is 5.67, which is 397.4% above the current share price.
The Reviva Pharmaceuticals Holdings 52-week low stock price is 0.60, which is 47.4% below the current share price.
The average Reviva Pharmaceuticals Holdings stock price for the last 52 weeks is 2.38.
An investor who bought $1,000 worth of Reviva Pharmaceuticals Holdings stock at the IPO in 2018 would have $-883 today, roughly -1 times their original investment - a -30.02% compound annual growth rate over 6 years.
The all-time high Reviva Pharmaceuticals Holdings stock closing price was 11.88 on September 28, 2020.
The Reviva Pharmaceuticals Holdings 52-week high stock price is 5.67, which is 397.4% above the current share price.
The Reviva Pharmaceuticals Holdings 52-week low stock price is 0.60, which is 47.4% below the current share price.
The average Reviva Pharmaceuticals Holdings stock price for the last 52 weeks is 2.38.